John R. Vogel

New survey captures sponsors changing global usage of, and relationships with, CRO partners.

Following more than two decades of growing involvement in nearly all aspects of drug development, full-service and niche-services contract research organizations (CROs) have become a common and integral part of most sponsor companies' clinical research teams.